1/9/2006 | CV | Market Commentary: Convertibles market extends gains; Human Genome, GM, Delta Air Lines, Duke up
|
11/15/2005 | CV | S&P removes Reebok from negative watch
|
10/24/2005 | CV | Market Commentary: Cephalon, Reebok, Nextel Partners lose; Albertson's, Halliburton gain; Essex Partners set to price
|
8/31/2005 | CV | Market Commentary: Moderate buying lifts convertibles of Cephalon, Micron, Maxtor; Emdeon, Mercury Interactive see interest
|
8/3/2005 | CV | Market Commentary: Human Genome to price $230 million of convertibles; Reebok paper jumps on buyout news
|
6/15/2005 | CV | Market Commentary: Convertibles catch wave of optimism as new Invitrogen deal gains favor; Saks sinks after default notice
|
5/25/2005 | CV | Moody's ups Reebok
|
3/22/2005 | CV | Moody's may up Reebok notes
|
11/24/2004 | CV | Reebok says 84.8% of 2% CoCo convertibles exchanged
|
10/27/2004 | CV | S&P rates Reebok convertibles BBB
|
10/26/2004 | CV | Reebok starts exchange for 2% CoCo convertibles
|
10/21/2004 | CV | Market Commentary: Kodak CDS spreads blow out; Tower 5.75s firm on financing noise; Reebok up on CoCo tender
|
10/21/2004 | CV | Reebok plans exchange for 2% CoCo convertibles
|
6/28/2004 | CV | S&P affirms Reebok
|
4/30/2004 | CV | Reebok calls 4.25% convertibles
|
4/30/2004 | CV | Reebok greenshoe exercised, raising convertibles to $350 million
|
4/30/2004 | CV | Market Commentary: Conseco deal seen May 3 week after delay due to warning; price talk emerges on Genworth deal
|
4/27/2004 | CV | S&P rates Reebok converts BBB
|
4/27/2004 | CV | New Issue: Reebok $300 million convertible yields 2.0%, up 35%
|
4/27/2004 | CV | Market Commentary: Reebok bounces to 102.25; OSI Pharma, cancer issues snap back; three deals at bat
|
4/26/2004 | CV | Market Commentary: OSI Pharma skyrockets amid buying frenzy as stock shoots up 139%; 4 new deals emerge
|
4/26/2004 | CV | Reebok $300 million overnighter talked at 1.75-2.25%, up 35-40%
|
3/26/2004 | CV | S&P raises Reebok ratings
|
10/24/2003 | CV | S&P puts Reebok on positive watch
|
8/26/2003 | CV | Market Commentary: Mixed bag, as convertibles track stocks in another slow session; Xerox issue soars on dividend
|
8/29/2002 | CV | Market Commentary: Nortel holders stage exodus; thin market mixed, apathetic
|
3/27/2002 | CV | S&P puts Adelphia on negative watch
|
3/25/2002 | CV | Moody's puts Solectron on review for downgrade
|